In the treatment of PCOS, the prolonged GnRH-agonist protocol has been shown to enhance endometrial receptivity by extending the down-regulating time, resulting in higher rates of implantation and pregnancy, without an increase in the occurrence of OHSS [20]. Here, GNRH1 is linked to polycystic ovary syndrome.